Delivery Order SPE2DB20D3103-SPE2DB25FQ3E9
- Not listed
- The Defense Logistics Agency awarded a $3,993.45 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Adenosine 12 mg/4 ml syringes. The contract, which is not set-aside and competitively awarded, represents a firm fixed price delivery order with an ultimate completion date of August 26, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,091.99 to AmerisourceBergen Drug Corp for the supply of Adenosine 12 mg/4 mL syringes on August 22, 2025, with completion expected by August 25, 2025. This firm fixed-price delivery order is being fulfilled from the company's place of performance in Conshohocken, Pennsylvania, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Adenosine 6 mg/2 ml syringes with a contract ceiling value of $2,801.95 and a completion date of September 10, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen Drug Corp's broader...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Adenosine 12 mg/4 mL syringes with a ceiling value of $1,183.83. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Adenosine 12 mg/4 mL syringes with a ceiling value of $1,027.81. This non-competitive delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. The contract utilizes firm fixed pricing under a delivery order arrangement, representing a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $1,136.88 delivery order to AmerisourceBergen Drug Corp for the supply of Adenosine 12 mg/4 mL vials on July 18, 2025, with completion targeted for July 21, 2025. The award utilizes firm fixed pricing with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Adenosine 12 mg/4 mL vials with a ceiling value of $1,084.19. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and no set-aside designation was used in the award. The work will be performed at the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Adenosine 12 mg/4 ml syringes. The contract has a potential value of $1,701.42 and a period of performance through January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors identified. This delivery order is issued under a larger indefinite delivery contract...
- The Defense Logistics Agency awarded a $3,574.64 delivery order to AmerisourceBergen Drug Corp for Adenosine 90 mg/30 mL vials on July 22, 2025, with completion scheduled for July 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery of this pharmaceutical product to support federal medical procurement needs within the Defense Logistics...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,292.82 to AmerisourceBergen Drug Corp for the supply of Adenosine 12mg/4mL in a quantity of 10 units. This firm fixed-price, competitively awarded delivery order was issued on December 21, 2024, with an ultimate completion date of the same day. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order from its Corporate...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ3E9Delivery Order
The Defense Logistics Agency awarded a $3,957.51 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Adenosine 6 mg/2 mL syringes. This firm fixed price contract, with an ultimate completion date of September 17, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively awarded through open procurement procedures. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As a prime vendor under the DLA Troop Support Medical contract, the company supplies a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Adenosine delivery represents a routine pharmaceutical supply requirement within AmerisourceBergen's broader role as a global pharmaceutical support vehicle for military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 9/16/25 |